Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8538
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTekgündüz, E.-
dc.contributor.authorAltuntaş, F.-
dc.contributor.authorŞivgin, S.-
dc.contributor.authorAki, Ş.Z.-
dc.contributor.authorDönmez, A.-
dc.contributor.authorTopçuoglu, P.-
dc.contributor.authorYildirim, R.-
dc.date.accessioned2019-08-16T12:42:05Z
dc.date.available2019-08-16T12:42:05Z
dc.date.issued2012-
dc.identifier.issn1473-0502-
dc.identifier.urihttps://hdl.handle.net/11499/8538-
dc.identifier.urihttps://doi.org/10.1016/j.transci.2012.05.004-
dc.description.abstractPlerixafor in conjunction with G-CSF (G-P) is an effective strategy for hematopoietic stem cell mobilization in patients with previously failed mobilization attempt. Here we report our results with G-P among patients with at least one mobilization failure with G-CSF alone (G) or G-CSF plus chemotherapy (G-C). The study included 20 consecutive patients with lymphoma and myeloma from five centers. In 14 (70%) patients, a minimum of 2×10 6/kg CD34+ stem cells were collected and 16 out of 20 patients (80%) were able to proceed to ASCT. Our study indicates that plerixafor can safely rescue patients with a history of mobilization failure. © 2012 Elsevier Ltd.en_US
dc.language.isoenen_US
dc.relation.ispartofTransfusion and Apheresis Scienceen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChemotherapyen_US
dc.subjectMobilization failureen_US
dc.subjectPlerixaforen_US
dc.subjectStem cell mobilizationen_US
dc.subjectgranulocyte colony stimulating factor receptoren_US
dc.subjectplerixaforen_US
dc.subjectabdominal painen_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectarticleen_US
dc.subjectautologous hematopoietic stem cell transplantationen_US
dc.subjectCD34+ stem cellen_US
dc.subjectchemotherapy induced emesisen_US
dc.subjectclinical articleen_US
dc.subjectdrug induced headacheen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectlymphomaen_US
dc.subjectmaleen_US
dc.subjectmulticenter studyen_US
dc.subjectmyalgiaen_US
dc.subjectmyelomaen_US
dc.subjectnauseaen_US
dc.subjectstem cellen_US
dc.subjectstem cell mobilizationen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAnti-HIV Agentsen_US
dc.subjectFemaleen_US
dc.subjectGranulocyte Colony-Stimulating Factoren_US
dc.subjectHematopoietic Stem Cell Mobilizationen_US
dc.subjectHeterocyclic Compoundsen_US
dc.subjectHumansen_US
dc.subjectLeukocyte Counten_US
dc.subjectLymphomaen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectMultiple Myelomaen_US
dc.subjectPeripheral Blood Stem Cell Transplantationen_US
dc.subjectTransplantation, Autologousen_US
dc.titlePlerixafor use in patients with previous mobilization failure: A multicenter experienceen_US
dc.typeArticleen_US
dc.identifier.volume47en_US
dc.identifier.issue1en_US
dc.identifier.startpage77
dc.identifier.startpage77en_US
dc.identifier.endpage80en_US
dc.identifier.doi10.1016/j.transci.2012.05.004-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid22609192en_US
dc.identifier.scopus2-s2.0-84862859727en_US
dc.identifier.wosWOS:000306389800015en_US
dc.identifier.scopusqualityQ3-
dc.ownerPamukkale University-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.grantfulltextnone-
item.cerifentitytypePublications-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

9
checked on Nov 23, 2024

WEB OF SCIENCETM
Citations

6
checked on Nov 24, 2024

Page view(s)

36
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.